Endothelin Receptor Antagonists for Kidney Protection: Lessons from the SONAR Trial.
作者信息
Heerspink Hiddo J L, de Zeeuw Dick
机构信息
Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
出版信息
Clin J Am Soc Nephrol. 2022 Jun;17(6):908-910. doi: 10.2215/CJN.00560122. Epub 2022 Apr 28.
Abstract
摘要
相似文献
1
Endothelin Receptor Antagonists for Kidney Protection: Lessons from the SONAR Trial.用于肾脏保护的内皮素受体拮抗剂：SONAR试验的经验教训。
Clin J Am Soc Nephrol. 2022 Jun;17(6):908-910. doi: 10.2215/CJN.00560122. Epub 2022 Apr 28.
2
Atrasentan for the treatment of diabetic nephropathy.阿曲生坦用于治疗糖尿病肾病。
Expert Opin Investig Drugs. 2017 Jun;26(6):741-750. doi: 10.1080/13543784.2017.1325872.
3
Endothelin receptor antagonists in clinical research--lessons learned from preclinical and clinical kidney studies.临床研究中的内皮素受体拮抗剂——来自临床前和临床肾脏研究的经验教训。
Life Sci. 2014 Nov 24;118(2):141-8. doi: 10.1016/j.lfs.2014.02.025. Epub 2014 Mar 4.
4
Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis.用于糖尿病肾病的内皮素受体拮抗剂：一项荟萃分析。
Nephrology (Carlton). 2015 Jul;20(7):459-66. doi: 10.1111/nep.12442.
5
Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease.内皮素受体拮抗剂治疗糖尿病和非糖尿病慢性肾脏病。
Curr Opin Nephrol Hypertens. 2021 Jul 1;30(4):456-465. doi: 10.1097/MNH.0000000000000716.
6
[Pharmacological and clinical profile of a novel dual endothelin receptor antagonist, macitentan (Opsumit)].新型双重内皮素受体拮抗剂马昔腾坦（Opsumit）的药理及临床概况
Nihon Yakurigaku Zasshi. 2017;149(1):49-58. doi: 10.1254/fpj.149.49.
7
Endothelin antagonists in clinical trials: lessons learned.临床试验中的内皮素拮抗剂：经验教训
Contrib Nephrol. 2011;172:255-260. doi: 10.1159/000328859. Epub 2011 Aug 30.
8
Therapeutic transformation for diabetic kidney disease.糖尿病肾病的治疗转变。
Kidney Int. 2021 Feb;99(2):301-303. doi: 10.1016/j.kint.2020.10.003.
9
Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.内皮素拮抗剂治疗糖尿病和非糖尿病慢性肾脏病。
Br J Clin Pharmacol. 2013 Oct;76(4):573-9. doi: 10.1111/bcp.12064.
10
Update on Endothelin Receptor Antagonists in Hypertension.高血压治疗中的内皮素受体拮抗剂更新。
Curr Hypertens Rep. 2018 May 19;20(6):51. doi: 10.1007/s11906-018-0848-0.
引用本文的文献
1
Endothelin-1 signaling in the kidney: recent advances and remaining gaps.肾脏中的内皮素-1信号传导：最新进展与尚存差距
Am J Physiol Renal Physiol. 2025 Jun 1;328(6):F815-F827. doi: 10.1152/ajprenal.00304.2024. Epub 2025 Apr 24.
2
Research trends and performance of endothelin A receptor antagonist in kidney care: a bibliometric analysis.内皮素A受体拮抗剂在肾脏护理中的研究趋势与表现：一项文献计量分析
Ren Fail. 2025 Dec;47(1):2487212. doi: 10.1080/0886022X.2025.2487212. Epub 2025 Apr 11.
3
Effects of combining zibotentan and dapagliflozins on chronic kidney disease: an innovative frontier.齐考诺肽与达格列净联合使用对慢性肾脏病的影响：一个创新前沿领域。
Int Urol Nephrol. 2025 May;57(5):1657-1658. doi: 10.1007/s11255-024-04310-3. Epub 2024 Dec 4.
4
Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease.糖尿病和非糖尿病慢性肾脏病中的内皮素受体拮抗剂
Clin Kidney J. 2024 Mar 19;17(4):sfae072. doi: 10.1093/ckj/sfae072. eCollection 2024 Apr.
5
Sparsentan is superior to losartan in the gddY mouse model of IgA nephropathy.斯巴森坦在 IgA 肾病的 gddY 小鼠模型中优于洛沙坦。
Nephrol Dial Transplant. 2024 Aug 30;39(9):1494-1503. doi: 10.1093/ndt/gfae021.
6
Central role of podocytes in mediating cellular cross talk in glomerular health and disease.足细胞在介导肾小球健康和疾病中的细胞串扰中起核心作用。
Am J Physiol Renal Physiol. 2024 Mar 1;326(3):F313-F325. doi: 10.1152/ajprenal.00328.2023. Epub 2024 Jan 11.
7
Treatment and practical considerations of diabetic kidney disease.糖尿病肾病的治疗与实际考量
Front Med (Lausanne). 2023 Dec 1;10:1264497. doi: 10.3389/fmed.2023.1264497. eCollection 2023.
8
Endothelin System in Hypertension and Chronic Kidney Disease.内皮素系统与高血压及慢性肾脏病。
Hypertension. 2024 Apr;81(4):691-701. doi: 10.1161/HYPERTENSIONAHA.123.21716. Epub 2023 Dec 7.
9
Add-on Rehmannia-6-Based Chinese Medicine in Type 2 Diabetes and CKD: A Multicenter Randomized Controlled Trial.基于加味地黄汤的中药治疗 2 型糖尿病合并非透析慢性肾脏病：一项多中心随机对照试验。
Clin J Am Soc Nephrol. 2023 Sep 1;18(9):1163-1174. doi: 10.2215/CJN.0000000000000199. Epub 2023 Jun 12.
10
Early diabetic kidney disease: Focus on the glycocalyx.早期糖尿病肾病：聚焦于糖萼。
World J Diabetes. 2023 May 15;14(5):460-480. doi: 10.4239/wjd.v14.i5.460.
Zotero 插件